The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Child development following in utero exposure: Levetiracetam vs sodium valproate
Open accessAbstract
OBJECTIVE: Children born to women with epilepsy (WWE), exposed in utero to levetiracetam (LEV, n = 51), were assessed for early cognitive development and compared to children exposed to sodium valproate in utero (VPA, n = 44) and a group of children representative of the general population (n = 97). METHODS: Children were recruited prospectively from 2 cohorts in the United Kingdom and assessed using the Griffiths Mental Development Scale (1996), aged <24 months. Information regarding maternal demographics were collected and controlled for. This is an observational study with researchers not involved in the clinical management of the WWE. RESULTS: On overall developmental ability, children exposed to LEV obtained higher developmental scores when compared to children exposed to VPA (p < 0.001). When compared, children exposed to LEV did not differ from control children (p = 0.62) on overall development. Eight percent of children exposed to LEV in utero fell within the below average range (DQ score of <84), compared with 40% of children exposed to VPA. After controlling for maternal epilepsy and demographic factors using linear regression analysis, exposure to LEV in utero was not associated with outcome (p = 0.67). Conversely, when compared with VPA exposure, LEV exposure was associated with higher scores for the overall developmental quotient (p < 0.001). CONCLUSION: Children exposed to LEV in utero are not at an increased risk of delayed early cognitive development under the age of 24 months. LEV may therefore be a preferable drug choice, where appropriate, for WWE prior to and of childbearing age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results are supported by findings from a cohort study, which found that children exposed to levetiracetam were not at increased risk for delayed development compared with unexposed children (see online supplementary appendix C).42”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morrow, J. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 879
Self-citationCognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Meador, K. J., Baker, G. A., Browning, N., Clayton-Smith, J., Combs-Cantrell, D. T., Cohen, M., Kalayjian, L. A., Kanner, A., Liporace, J. D., Pennell, P. B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803531 · Cited by 812
Self-citationAntiepileptic drugs and apoptotic neurodegeneration in the developing brain
Bittigau, P., Sifringer, M., Genz, K., Reith, E., Pospischil, D., Govindarajalu, S., Dzietko, M., Pesditschek, S., Mai, I., Dikranian, K. T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222550499 · Cited by 784
The longer term outcome of children born to mothers with epilepsy
Adab, N. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029132 · Cited by 579
Samrén, E. B., van Duijn, C. M., Koch, S., Hiilesmaa, V. K., Klepel, H., Bardy, A. H., Mannagetta, G. B., Deichl, A. W., Gaily, E., Granström, I. L., et al. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01480.x · Cited by 406
Venegas, J., & Clark, E. (2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_1467 · Cited by 384
Hunt, S., Russell, A., Smithson, W. H., Parsons, L., Robertson, I., Waddell, R., Irwin, B., Morrison, P. J., Morrow, J. I., & Craig, J. J. (2008) · Neurology · doi:10.1212/01.wnl.0000318293.28278.33 · Cited by 313
Self-citationNormal intelligence in children with prenatal exposure to carbamazepine
Gaily, E. K., Kantola‐Sorsa, E., Hiilesmaa, V., ISOAHO, M., Matila, R., Kotila, M., Nylund, T., Bardy, A. H., Kaaja, E., & Granström, M.-L. (2004) · Neurology · doi:10.1212/wnl.62.1.28 · Cited by 295
Levetiracetam in the treatment of epilepsy
Abou-Khalil, B. W. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2937 · Cited by 233
Affect of Seizures During Gestation on Pregnancy Outcomes in Women With Epilepsy
Chen, Y., Chiou, H., Lin, H., & Lin, H. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.142 · Cited by 191
Research works printed but not linked: 1
- Bromley RL, Gummery A, Shallcross R, et al.. IQ, memory, language and attention in children exposed to antiepileptic drugs in utero: preliminary outcomes at 6 years of age. Epilepsia 2009;50:491.Abstract.
Cited by
Sorted by citations
The valproic acid-induced rodent model of autism
Nicolini, C., & Fahnestock, M. L. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.017 · Cited by 622
In utero exposure to valproic acid and autism — A current review of clinical and animal studies
Roullet, F., Lai, J., & Foster, J. A. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2013.01.004 · Cited by 444
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Romoli, M., Mazzocchetti, P., D’Alonzo, R., Siliquini, S., Rinaldi, V. E., Verrotti, A., Calabresi, P., & Costa, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x17666181227165722 · Cited by 390
Mandy, W., & Lai, M. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12501 · Cited by 283
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child
Bromley, R., Weston, J., Adab, N., Greenhalgh, J., Sanniti, A., McKay, A. J., Smith, C. T., & Marson, A. G. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010236.pub2 · Cited by 279
Self-citationTeratogenic effects of antiepileptic drugs
Tomson, T., & Battino, D. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70103-5 · Cited by 277
Tomson, T., Battino, D., Bromley, R., Kochen, S. S., Meador, K. J., Pennell, P. B., & Thomas, S. V. (2019) · Epileptic Disorders · doi:10.1684/epd.2019.1105 · Cited by 260
Self-citationVeroniki, A. A., Rios, P., Cogo, E., Straus, S. E., Finkelstein, Y., Kealey, R., Reynen, E., Soobiah, C., Thavorn, K., Hutton, B., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017248 · Cited by 222
Levetiracetam: a review of its use in epilepsy.
Lyseng-Williamson, K. A. (2011) · PubMed · doi:10.2165/11204490-000000000-00000 · Cited by 205
Kwan, P., Trinka, E., Paesschen, W. V., Rektor, I., Johnson, M. E., & Lu, S. Q. (2013) · Epilepsia · doi:10.1111/epi.12391 · Cited by 163
Mawhinney, E., Craig, J. J., Morrow, J. I., Russell, A., Smithson, W. H., Parsons, L., Morrison, P. J., Liggan, B., Irwin, B., Delanty, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0874 · Cited by 163
Self-citationAntiepileptic drugs and pregnancy outcomes
Wlodarczyk, B. J., Palacios, A. M., George, T. M., & Finnell, R. H. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35438 · Cited by 138
Maitre, N. L., Smolinsky, C., Slaughter, J. C., & Stark, A. R. (2013) · Journal of Perinatology · doi:10.1038/jp.2013.116 · Cited by 138
Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate
Bromley, R., Calderbank, R., Cheyne, C. P., Rooney, C., Trayner, P., Clayton‐Smith, J., García‐Fiñana, M., Irwin, B., Morrow, J., Shallcross, R., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003157 · Cited by 132
Self-citationEffects of fetal antiepileptic drug exposure
Meador, K. J., Baker, G. A., Browning, N., Cohen, M. J., Bromley, R., Clayton‐Smith, J., Kalayjian, L. A., Kanner, A. M., Liporace, J. D., Pennell, P. B., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318250d824 · Cited by 130
Self-citationTrinka, E., Marson, A. G., Van Paesschen, W., Kälviäinen, R., Marovac, J., Duncan, B., Buyle, S., Hallström, Y., Hon, P., Muscas, G. C., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300376 · Cited by 121
The Long-Term Safety of Antiepileptic Drugs
Gaitatzis, A., & Sander, J. W. A. S. (2013) · CNS Drugs · doi:10.1007/s40263-013-0063-0 · Cited by 108
Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy
Voinescu, P. E., Park, S., Chen, L. Q., Stowe, Z. N., Newport, D. J., Ritchie, J., & Pennell, P. B. (2018) · Neurology · doi:10.1212/wnl.0000000000006240 · Cited by 101
Blotière, P., Miranda, S., Weill, A., Mikaeloff, Y., Peyre, H., Ramus, F., Zureik, M., Coste, J., & Dray‐Spira, R. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034829 · Cited by 94
In utero exposure to levetiracetam vs valproate
Shallcross, R., Bromley, R., Cheyne, C. P., García‐Fiñana, M., Irwin, B., Morrow, J. I., & Baker, G. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000030 · Cited by 93
Self-citationSeizures in pregnancy: Epilepsy, eclampsia, and stroke
Hart, L. A., & Sibai, B. M. (2013) · Seminars in Perinatology · doi:10.1053/j.semperi.2013.04.001 · Cited by 90
Management of epilepsy during pregnancy
Voinescu, P. E., & Pennell, P. B. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1083422 · Cited by 77
Ornoy, A., Echefu, B. E., & Becker, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010390 · Cited by 77
Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine
Deshmukh, U. S., Adams, J., Macklin, E. A., Dhillon, R., McCarthy, K., Dworetzky, B. A., Klein, A., & Holmes, L. B. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.01.001 · Cited by 71
A Systematic Review of the Efficacy of Levetiracetam in Neonatal Seizures
McHugh, D. C., Lancaster, S., & Manganas, L. N. (2017) · Neuropediatrics · doi:10.1055/s-0037-1608653 · Cited by 68
Fetal antiepileptic drug exposure and cognitive outcomes
Bromley, R., & Baker, G. A. (2016) · Seizure · doi:10.1016/j.seizure.2016.10.006 · Cited by 61
Self-citationAn Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes
Meador, K. J., & Gerard, E. E. (2015) · Journal of Pediatric Genetics · doi:10.1055/s-0035-1556741 · Cited by 59
Antiepileptic drugs in women with epilepsy during pregnancy
Gedzelman, E., & Meador, K. J. (2012) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098611433192 · Cited by 57
Knight, R. A., Wittkowski, A., & Bromley, R. (2021) · Epilepsia · doi:10.1111/epi.16953 · Cited by 57
Self-citationThree Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
Zárate-López, D., Torres-Chávez, A. L., Gálvez‐Contreras, A. Y., & González-Pérez, Ó. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231003121513 · Cited by 62
Shojaei, S., Ali, M. S., Suresh, M., Upreti, T., Mogourian, V., Helewa, M. E., & Labouta, H. I. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166131 · Cited by 55
The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy
Vajda, F. J. E., O'Brien, T. J., Lander, C. M., Graham, J. E., & Eadie, M. J. (2014) · Epilepsia · doi:10.1111/epi.12711 · Cited by 55
Delanty, N., Jones, J. J., & Tonner, F. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03300.x · Cited by 53
Second-generation antiepileptic drugs and pregnancy: a guide for clinicians
Reimers, A., & Brodtkorb, E. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.32 · Cited by 51
Neurodevelopmental and Functional Outcomes Following In Utero Exposure to Antiseizure Medication
Honybun, E., Cockle, E., Malpas, C. B., O'Brien, T. J., Vajda, F. J. E., Perucca, P., & Rayner, G. (2024) · Neurology · doi:10.1212/wnl.0000000000209175 · Cited by 49
The Epilepsy Prescriber's Guide to Antiepileptic Drugs
Patsalos, P. N., & Bourgeois, B. F. D. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511730221 · Cited by 49
Neurodevelopmental effects of fetal antiepileptic drug exposure
Velez-Ruiz, N. J., & Meador, K. J. (2015) · Drug Safety · doi:10.1007/s40264-015-0269-9 · Cited by 48
Gender issues in antiepileptic drug treatment
Perucca, E., Battino, D., & Tomson, T. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.011 · Cited by 46
Valproate prescriptions for nonepilepsy disorders in reproductive‐age women
Adedinsewo, D. A., Thurman, D. J., Luo, Y., Williamson, R. S., Odewole, O. A., & Oakley, G. P. (2013) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23147 · Cited by 46
Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014
Ahmad, K. A., Desai, S., Bennett, M., Ahmad, S. F., Ng, Y.-T., Clark, R. H., & Tolia, V. N. (2016) · Journal of Perinatology · doi:10.1038/jp.2016.206 · Cited by 43
van Woudenberg, A. B., Snel, C. J., Rijkmans, E., de Groot, D., Bouma, M. J., Hermsen, S. A. B., Piersma, A. H., Menke, A. L., & Wolterbeek, A. P. M. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.07.082 · Cited by 44
Gentile, S. (2014) · CNS Spectrums · doi:10.1017/s1092852913000990 · Cited by 42
Modeling dopamine dysfunction in autism spectrum disorder: from invertebrates to vertebrates
DiCarlo, G. E., & Wallace, M. T. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.017 · Cited by 39
Cognitive and neurodevelopmental effects of antiepileptic drugs
Bromley, R., Leeman, B. A., Baker, G. A., & Meador, K. J. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.04.009 · Cited by 38
Self-citationUse of Psychotropic Medication during Pregnancy and the Postpartum Period
Pearlstein, T. B. (2013) · Women s Health · doi:10.2217/whe.13.54 · Cited by 37
Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential
Serafini, A., Gerard, E. E., Genton, P., Crespel, A., & Gélisse, P. (2019) · CNS Drugs · doi:10.1007/s40263-018-00602-2 · Cited by 35
Autism Spectrum Disorder-Related Syndromes: Modeling with Drosophila and Rodents
Ueoka, I., Pham, H. T. N., Matsumoto, K., & Yamaguchi, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174071 · Cited by 39
Cheaha, D., Bumrungsri, S., Chatpun, S., & Kumarnsit, E. (2015) · Neuroscience Research · doi:10.1016/j.neures.2015.04.006 · Cited by 35
Management of glioblastoma multiforme in pregnancy
Jayasekera, B. A. P., Bacon, A., & Whitfield, P. C. (2012) · Journal of neurosurgery · doi:10.3171/2012.2.jns112077 · Cited by 32
Issues for Women with Epilepsy
Velez-Ruiz, N. J., & Pennell, P. B. (2016) · Neurologic Clinics · doi:10.1016/j.ncl.2015.11.009 · Cited by 31
Bromley, R. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.06.007 · Cited by 31
Self-citationLenart, J., Augustyniak, J., Łazarewicz, J. W., & Ziemińska, E. (2020) · Toxicology · doi:10.1016/j.tox.2020.152500 · Cited by 31
The fetal safety of Levetiracetam: A systematic review
Chaudhry, S. A., Jong, G., & Koren, G. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.02.004 · Cited by 30
Gopinath, N., Muneer, A. K., Syam, U. K., Varma, R. P., & Thomas, S. V. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.09.003 · Cited by 30
Mood stabilizers in pregnancy and lactation
Grover, S., & Avasthi, A. (2015) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.161498 · Cited by 29
Harden, C. L. (2014) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000443837.95260.af · Cited by 28
Taiwan consensus of pharmacological treatment for bipolar disorder
Bai, Y., Chang, C.-J., Tsai, S., Chen, Y.-C., Hsiao, M., Li, C., Tu, P., Chang, S., Shen, W. W., & Su, T. (2013) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2013.06.013 · Cited by 27
Cognitive outcomes of prenatal antiepileptic drug exposure
Inoyama, K., & Meador, K. J. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.04.016 · Cited by 27
Ehashi, T., Suzuki, N., Ando, S., Sumida, K., & Saito, K. (2014) · The Journal of Toxicological Sciences · doi:10.2131/jts.39.383 · Cited by 26
Kinney, M. O., & Morrow, J. (2016) · BMJ · doi:10.1136/bmj.i2880 · Cited by 25
Self-citationCognitive functions in children exposed to antiepileptic drugs in utero - Study in Georgia
Kasradze, S., Gogatishvili, N., Lomidze, G., Ediberidze, T., Lazariashvili, M., Khomeriki, K., Mamukadze, S., Metreveli, M., Gagoshidze, T. S., Tatishvili, N. N., et al. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.10.014 · Cited by 25
Delivery of a Personalized Treatment Approach to Women with Epilepsy
Pennell, P. B., & Voinescu, P. E. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608932 · Cited by 25
Bertsche, A., Neininger, M. P., Dahse, A.-J., Syrbe, S., Bernhard, M. K., Frontini, R., Kieß, W., Bertsche, T., & Merkenschlager, A. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2125-1 · Cited by 24
Epilepsy and pregnancy: What should the neurologists do?
Dupont, S., & Vercueil, L. (2021) · Revue Neurologique · doi:10.1016/j.neurol.2021.01.003 · Cited by 21
Therapeutic drug monitoring in pregnancy: Levetiracetam
Fallik, N., Trakhtenbroit, I., Fahoum, F., & Goldstein, L. (2024) · Epilepsia · doi:10.1111/epi.17925 · Cited by 20
Neurological and Psychiatric Sequelae of Developmental Exposure to Antiepileptic Drugs
Gedzelman, E. R., & Meador, K. J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00182 · Cited by 20
Foetal safety of old and new antiepileptic drugs
Verrotti, A., Mencaroni, E., Castagnino, M., & Zaccara, G. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1084288 · Cited by 19
Educational attainment of children born to mothers with epilepsy
Lacey, A., Pickrell, W. O., Thomas, R. H., Kerr, M. P., White, C., & Rees, M. I. (2018) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-317515 · Cited by 19
Marxer, C. A., Rüegg, S. J., Rauch, M., Panchaud, A., Meier, C. R., & Spoendlin, J. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1943355 · Cited by 18
Wang, Y., Luo, S., Wang, K., Hou, Y., Yan, H., & Zhang, Y. (2022) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-022-01380-w · Cited by 17
Does in utero exposure of antiepileptic drugs lead to failure to reach full cognitive potential?
McCorry, D., & Bromley, R. (2015) · Seizure · doi:10.1016/j.seizure.2015.01.019 · Cited by 16
Self-citationNeurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review
Bromley, R., & Bluett‐Duncan, M. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210716111814 · Cited by 16
Self-citationBoon, P., Engelborghs, S., Hauman, H., Jansen, A., Lagae, L. G., Legros, B., Ossemann, M., Sadzot, B., Smets, K., Urbain, E., et al. (2012) · Acta Neurologica Belgica · doi:10.1007/s13760-012-0070-9 · Cited by 16
Effects of Maternal Use of Antiseizure Medications on Child Development
Meador, K. J. (2022) · Neurologic Clinics · doi:10.1016/j.ncl.2022.03.006 · Cited by 15
Leung, C. S., Rosenzweig, S. J., Yoon, B., Marinelli, N. A., Hollingsworth, E. W., Maguire, A. M., Cowen, M. H., Schmidt, M., Imitola, J., Uzun, E. D. G., et al. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad002 · Cited by 16
Li, Y., Wang, M., Guo, Y., Cao, Y., Zhao, M., & Zhao, L. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15572 · Cited by 13
Managing Epilepsy During Pregnancy: Assessing Risk and Optimizing Care
Krishnamurthy, K. B. (2012) · Current Treatment Options in Neurology · doi:10.1007/s11940-012-0184-7 · Cited by 13
Neurodevelopment of babies born to mothers with epilepsy: A prospective observational cohort study
Bromley, R., Bullen, P., Campbell, E., Craig, J. J., Ingham, A., Irwin, B., Jackson, C., Kelly, T., Morrow, J., Rushton, S., et al. (2023) · Epilepsia · doi:10.1111/epi.17709 · Cited by 12
Self-citationLevetiracetam: More Evidence of Safety in Pregnancy
Koubeissi, M. Z. (2013) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597-13.6.279 · Cited by 12
The neurotoxic effects of prenatal gabapentin and oxcarbazepine exposure on newborn rats
Erişgin, Z., Ayas, B., Nyengaard, J. R., Beyhun, N. E., & Terzi, Y. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1383378 · Cited by 11
[Improvement of a mouse model of valproic acid-induced autism].
Zheng, W., Hu, Y., Chen, D., Li, Y., & Wang, S. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.06.14 · Cited by 11
Levetiracetam bei generalisierten Epilepsien des Erwachsenenalters
Steinhoff, B. J., Kurth, C., & Dennig, D. (2012) · Clinical Epileptology · doi:10.1007/s10309-012-0237-7 · Cited by 10
Effects of Levetiracetam on neural tube development and closure of the chick embryos in ovo
Özer, F. D., Demirel, A., Yılmaz, Ö., Aydın, M., Özdemir, N., Uyanıkgil, Y., & Baka, M. (2012) · Child s Nervous System · doi:10.1007/s00381-012-1758-0 · Cited by 10
Neurodevelopmental outcomes in children exposed prenatally to levetiracetam
Alsfouk, B. A. A. (2022) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986221088419 · Cited by 9
Treating epilepsy in pregnant women
Eadie, M. J. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.896902 · Cited by 9
Widatalla, N., Khandoker, A. H., Yoshida, C., Nakanishi, K., Fukase, M., Suzuki, A., Saito, M., Kimura, Y., & Kasahara, Y. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.998695 · Cited by 8
Frequently asked questions on epilepsy, pregnancy and lactation: A EURAP-NL report
Rapcencu, A. E., Lindhout, D., & Bulk, S. (2012) · Seizure · doi:10.1016/j.seizure.2012.06.011 · Cited by 8
Management of epilepsy during pregnancy: evidence-based strategies
Putta, S., & Pennell, P. B. (2015) · Future Neurology · doi:10.2217/fnl.15.4 · Cited by 8
Kantarcı, B. C., Sanli, A., Gavaş, Ş., Toplu, A., Aşık, Z. N. T., Çilingir‐Kaya, Ö. T., Gulcebi, M. I., Ercan, F., & Onat, F. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136574 · Cited by 7
Zheng, S., & Chen, C. (2025) · Journal of Neural Transmission · doi:10.1007/s00702-025-02919-x · Cited by 6
Alsfouk, B. A. A., Almarzouqi, M. R., Alageel, S., Alsfouk, A. A., & Alsemari, A. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.12.006 · Cited by 6
Auvin, S. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1195809 · Cited by 6
Epilepsy and antiepileptic medications
Chambers, C., & Schaefer, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408078-2.00011-1 · Cited by 5
Long-term consequences after exposure to antiepileptic drugs in utero
Forsberg, L., & Wide, K. (2011) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098611419003 · Cited by 5
Psychopharmacological Treatment of Mood and Anxiety Disorders During Pregnancy
Krüger, S. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-30726-3_14 · Cited by 5
Sodium valproate effects on the morphological and neurobehavioral phenotype of zebrafish
Caioni, G., Merola, C., Perugini, M., Angelozzi, G., Amorena, M., Benedetti, E., Lucon‐Xiccato, T., & Bertolucci, C. (2024) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2024.104500 · Cited by 4
Guidotti, I., Lugli, L., Ori, L., Roversi, M. F., Muttini, E. D. C., Bedetti, L., Pugliese, M., Cavalleri, F., Stefanelli, F., Ferrari, F., et al. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2105698 · Cited by 4
Issues of Women with Epilepsy and Suitable Antiseizure Drugs
Lee, S. K. (2023) · Journal of Epilepsy Research · doi:10.14581/jer.23005 · Cited by 4
Preconception counseling for women with epilepsy
Gerard, E. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139178020.012 · Cited by 4
Maternal and neonatal complications during pregnancy in women with epilepsy
Bansal, R., Jain, G., Kharbanda, P., Goyal, M., & Suri, V. (2016) · International Journal of Epilepsy · doi:10.1016/j.ijep.2016.09.001 · Cited by 4
Metadata
- Authors
- Shallcross, R., Bromley, R. L., Irwin, B., Bonnett, L. J., Morrow, J., & Baker, G. A.
- Affiliations
- University of Liverpool (GB)
- Venue
- Neurology
- Published
- 2011-01-25
- Volume
- 76
- Issue
- 4
- Pages
- 383-389
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3271390
- OpenAlex
- W2031334993
- Cited by
- 161
- References
- 26
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 12 · 2021: 9 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 12 · 2015: 14 · 2014: 17 · 2013: 21 · 2012: 24
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- Bristol Research (University of Bristol) (submittedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- Pfizer
- GlaxoSmithKline
- Epilepsy Research UK
- Research Councils UK
- Eisai
- National Institutes of Health
- Medical Research Council
- National Institute of Neurological Disorders and Stroke (R01NS038455)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
- Keywords
- maternal epilepsy, prenatal drug exposure, levetiracetam, valproic acid, child cognitive development, developmental quotient, antiepileptic drugs, pregnancy, Griffiths Mental Development Scales
- MeSH terms
- Levetiracetam, Anticonvulsants, Child Development, Child, Preschool, Cognition, Epilepsy, Female, Humans, Infant, Maternal-Fetal Exchange, Piracetam, Pregnancy, Pregnancy Complications, Prenatal Exposure Delayed Effects, Retrospective Studies, Valproic Acid, Maternal Exposure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
